Last 12 months
Inside the activity.
0 purchase rows · 143 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 34 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 92 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2015 Filed Feb 25, 2015 23:25 UTC |
Malus Alan JExecutive Vice President
|
Tax withholdingCommon Stock | 3,246 | $130.98 | $425,161.08 |
DisclosureSEC source: 0001127602-15-008404 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,976 Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 23:28 UTC |
WILVER PETER MSr. VP & CFO
|
Tax withholdingCommon Stock | 2,771 | $130.98 | $362,945.58 |
DisclosureSEC source: 0001127602-15-008409 · form4.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,346 Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 00:13 UTC |
WILVER PETER MSr. VP & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,700 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-15-007783 · form4.xml · derivative · entry 4 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,700 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in four equal installments on March 5, 2011, 2012, 2013 and 2014. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 00:13 UTC |
WILVER PETER MSr. VP & CFO
|
SaleCommon Stock | 5,100 | $130.81 | $667,131.00 |
DisclosureSEC source: 0001127602-15-007783 · form4.xml · nonDerivative · entry 3 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,117 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.56 to $131.16, inclusive. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 00:13 UTC |
WILVER PETER MSr. VP & CFO
|
SaleCommon Stock | 45,600 | $130.04 | $5,929,824.00 |
DisclosureSEC source: 0001127602-15-007783 · form4.xml · nonDerivative · entry 2 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,217 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.94 to $130.55, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 00:13 UTC |
WILVER PETER MSr. VP & CFO
|
Exercise / conversionCommon Stock | 50,700 | $49.49 | $2,509,143.00 |
DisclosureSEC source: 0001127602-15-007783 · form4.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 00:15 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,037 | $0.00 Strike: $54.97 | $0.00 |
DisclosureSEC source: 0001127602-15-007785 · form4.xml · derivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,013 Underlying: Common Stock · 15,037 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 23, 2012, 2013, and 2014, and the last installment becomes exercisable on February 23, 2015. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 00:15 UTC |
Loewald Thomas WSenior Vice President
|
SaleCommon Stock | 15,037 | $127.94 | $1,923,833.78 |
DisclosureSEC source: 0001127602-15-007785 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,862 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.78 to $128.27, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 00:15 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionCommon Stock | 15,037 | $54.97 | $826,583.89 |
DisclosureSEC source: 0001127602-15-007785 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2015 Filed Feb 18, 2015 21:43 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 11,497 | $127.61 | $1,467,132.17 |
DisclosureSEC source: 0001127602-15-006774 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,233.53 Read SEC document |
| February 05, 2015 Filed Feb 6, 2015 21:40 UTC |
Malus Alan JExecutive Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $58.40 | $0.00 |
DisclosureSEC source: 0001127602-15-004859 · form4.xml · derivative · entry 5 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2015-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in five equal installments on July 10, 2009, 2010, 2011, 2012 and 2013. Read SEC document |
| February 05, 2015 Filed Feb 6, 2015 21:40 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 22,912 | $126.64 | $2,901,575.68 |
DisclosureSEC source: 0001127602-15-004859 · form4.xml · nonDerivative · entry 3 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2014. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.22 to $126.85, inclusive. Read SEC document |
| February 05, 2015 Filed Feb 6, 2015 21:40 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 27,088 | $126.99 | $3,439,905.12 |
DisclosureSEC source: 0001127602-15-004859 · form4.xml · nonDerivative · entry 2 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,134 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2014. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.86 to $127.40, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 05, 2015 Filed Feb 6, 2015 21:40 UTC |
Malus Alan JExecutive Vice President
|
Exercise / conversionCommon Stock | 50,000 | $58.40 | $2,920,000.00 |
DisclosureSEC source: 0001127602-15-004859 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2014 Filed Jan 5, 2015 21:35 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 229.47 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-15-000435 · doc1.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,323.73 Underlying: Common Stock · 229.47 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of December 31, 2014, at a price of $125.29 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of December 31, 2014, at a price of $125.29 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of December 31, 2014, at a price of $125.29 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| December 18, 2014 Filed Dec 22, 2014 22:05 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 11,618 | $125.20 | $1,454,573.60 |
DisclosureSEC source: 0001127602-14-035846 · form4.xml · nonDerivative · entry 2 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2014. Read SEC document |
| November 19, 2014 Filed Nov 20, 2014 23:17 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,987 | $0.00 Strike: $54.97 | $0.00 |
DisclosureSEC source: 0001127602-14-033054 · form4.xml · derivative · entry 6 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,663 Underlying: Common Stock · 4,987 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 23, 2012. Read SEC document |
| November 19, 2014 Filed Nov 20, 2014 23:17 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-033054 · form4.xml · derivative · entry 5 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,600 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in four equal installments on March 5, 2011, 2012, 2013, and 2014. Read SEC document |
| November 19, 2014 Filed Nov 20, 2014 23:17 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
SaleCommon Stock | 8,363 | $125.00 | $1,045,375.00 |
DisclosureSEC source: 0001127602-14-033054 · form4.xml · nonDerivative · entry 3 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,138 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2014. Read SEC document |
| November 19, 2014 Filed Nov 20, 2014 23:17 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 4,987 | $54.97 | $274,135.39 |
DisclosureSEC source: 0001127602-14-033054 · form4.xml · nonDerivative · entry 2 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2014 Filed Nov 20, 2014 23:17 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 1,600 | $49.49 | $79,184.00 |
DisclosureSEC source: 0001127602-14-033054 · form4.xml · nonDerivative · entry 1 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2014 Filed Feb 13, 2015 22:02 UTC |
MANZI JIM PDirector
|
GiftCommon Stock | 230 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-006059 · form5.xml · nonDerivative · entry 1 MANZI JIM P · CIK 0001216076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,078 Read SEC document |
| November 12, 2014 Filed Feb 13, 2015 22:02 UTC |
MANZI JIM PDirector
|
GiftCommon Stock | 1,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-006059 · form5.xml · nonDerivative · entry 2 MANZI JIM P · CIK 0001216076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,783 Read SEC document |
| November 12, 2014 Filed Feb 13, 2015 21:58 UTC |
Jacks TylerDirector
|
GiftCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-006054 · form5.xml · nonDerivative · entry 1 Jacks Tyler · CIK 0001464237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,384 Read SEC document |
| September 27, 2014 Filed Sep 30, 2014 20:30 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 236.9 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-14-036783 · doc1.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,094.26 Underlying: Common Stock · 236.9 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of September 27, 2014, at a price of $121.36 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of September 27, 2014, at a price of $121.36 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of September 27, 2014, at a price of $121.36 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| September 09, 2014 Filed Dec 22, 2014 22:05 UTC |
Malus Alan JExecutive Vice President
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-035846 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,840 Read SEC document |
| September 02, 2014 Filed Sep 4, 2014 20:53 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 53,437 | $0.00 Strike: $54.97 | $0.00 |
DisclosureSEC source: 0001127602-14-027217 · form4.xml · derivative · entry 4 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,813 Underlying: Common Stock · 53,437 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 23, 2012, 2013 and 2014, and the next installment becomes exercisable on February 23, 2015. Read SEC document |
| September 02, 2014 Filed Sep 4, 2014 20:53 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 47,337 | $122.06 | $5,777,954.22 |
DisclosureSEC source: 0001127602-14-027217 · form4.xml · nonDerivative · entry 3 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,501 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.61 to $122.55, inclusive. Read SEC document |
| September 02, 2014 Filed Sep 4, 2014 20:53 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 20,644 | $121.28 | $2,503,704.32 |
DisclosureSEC source: 0001127602-14-027217 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,838 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.64 to $121.60, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| September 02, 2014 Filed Sep 4, 2014 20:53 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionCommon Stock | 53,437 | $54.97 | $2,937,431.89 |
DisclosureSEC source: 0001127602-14-027217 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2014 Filed Aug 28, 2014 23:27 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,775 | $0.00 Strike: $54.97 | $0.00 |
DisclosureSEC source: 0001127602-14-026756 · form4.xml · derivative · entry 7 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,325 Underlying: Common Stock · 7,775 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 23, 2012, 2013 and 2014, and the next installment becomes exercisable on February 23, 2015. Read SEC document |
| August 27, 2014 Filed Aug 28, 2014 23:27 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,812 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-026756 · form4.xml · derivative · entry 6 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,813 Underlying: Common Stock · 1,812 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2012, 2013 and 2014, and the next installment becomes exercisable on March 5, 2015. Read SEC document |
| August 27, 2014 Filed Aug 28, 2014 23:27 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
SaleCommon Stock | 10,577 | $120.77 | $1,277,384.29 |
DisclosureSEC source: 0001127602-14-026756 · form4.xml · nonDerivative · entry 4 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,348 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2014. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.49 to $120.90, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 27, 2014 Filed Aug 28, 2014 23:27 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionCommon Stock | 7,775 | $54.97 | $427,391.75 |
DisclosureSEC source: 0001127602-14-026756 · form4.xml · nonDerivative · entry 3 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2014 Filed Aug 28, 2014 23:27 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionCommon Stock | 1,812 | $49.49 | $89,675.88 |
DisclosureSEC source: 0001127602-14-026756 · form4.xml · nonDerivative · entry 2 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2014 Filed Aug 28, 2014 23:30 UTC |
Loewald Thomas WSenior Vice President
|
SaleCommon Stock | 2,349 | $120.90 | $283,994.10 |
DisclosureSEC source: 0001127602-14-026758 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,862 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 25, 2014. Read SEC document |
| August 27, 2014 Filed Aug 28, 2014 23:32 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 13,115 | $120.61 | $1,581,800.15 |
DisclosureSEC source: 0001127602-14-026759 · form4.xml · nonDerivative · entry 3 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,840 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.28 to $120.90, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 26, 2014 Filed Aug 28, 2014 23:25 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 7,771 | $120.71 | $938,037.41 |
DisclosureSEC source: 0001127602-14-026755 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 363,730.53 F1 · balance_after: Reflects reconciliation of shares for withholding tax purposes in connection with the vesting of restricted stock units allocated between the Reporting Person and his ex-spouse pursuant to a divorce decree. Read SEC document |
| August 26, 2014 Filed Aug 28, 2014 23:27 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Tax withholdingCommon Stock | 1,154 | $120.71 | $139,299.34 |
DisclosureSEC source: 0001127602-14-026756 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,338 Read SEC document |
| August 26, 2014 Filed Aug 28, 2014 23:28 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 227 | $120.71 | $27,401.17 |
DisclosureSEC source: 0001127602-14-026757 · form4.xml · nonDerivative · entry 1 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,914 Read SEC document |
| August 26, 2014 Filed Aug 28, 2014 23:30 UTC |
Loewald Thomas WSenior Vice President
|
Tax withholdingCommon Stock | 2,096 | $120.71 | $253,008.16 |
DisclosureSEC source: 0001127602-14-026758 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,211 Read SEC document |
| August 26, 2014 Filed Aug 28, 2014 23:32 UTC |
Malus Alan JExecutive Vice President
|
Tax withholdingCommon Stock | 3,004 | $120.71 | $362,612.84 |
DisclosureSEC source: 0001127602-14-026759 · form4.xml · nonDerivative · entry 2 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,955 Read SEC document |
| August 26, 2014 Filed Aug 28, 2014 23:34 UTC |
Pesicka Edward ASenior Vice President
|
Tax withholdingCommon Stock | 2,785 | $120.71 | $336,177.35 |
DisclosureSEC source: 0001127602-14-026760 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,045 Read SEC document |
| August 26, 2014 Filed Aug 28, 2014 23:36 UTC |
Stevenson Mark PExecutive Vice President
|
Tax withholdingCommon Stock | 1,703 | $120.71 | $205,569.13 |
DisclosureSEC source: 0001127602-14-026761 · form4.xml · nonDerivative · entry 1 Stevenson Mark · CIK 0001387890 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,047 Read SEC document |
| August 26, 2014 Filed Aug 28, 2014 23:38 UTC |
Thomson Andrew JSenior Vice President
|
Tax withholdingCommon Stock | 2,121 | $120.71 | $256,025.91 |
DisclosureSEC source: 0001127602-14-026762 · form4.xml · nonDerivative · entry 1 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,499 Read SEC document |
| August 26, 2014 Filed Aug 28, 2014 23:39 UTC |
WILVER PETER MSr. VP & CFO
|
Tax withholdingCommon Stock | 2,297 | $120.71 | $277,270.87 |
DisclosureSEC source: 0001127602-14-026763 · form4.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,117 Read SEC document |
| July 30, 2014 Filed Aug 1, 2014 21:11 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
SaleCommon Stock | 5,103 | $123.82 | $631,853.46 |
DisclosureSEC source: 0001127602-14-024476 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,492 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.54 to $124.22, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 25, 2014 Filed Jul 29, 2014 20:30 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $54.97 | $0.00 |
DisclosureSEC source: 0001127602-14-024049 · form4.xml · derivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,050 Underlying: Common Stock · 6,000 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 23, 2012, 2013, and 2014, and the last installment becomes exercisable on February 23, 2015. Read SEC document |
| July 25, 2014 Filed Jul 29, 2014 20:30 UTC |
Loewald Thomas WSenior Vice President
|
SaleCommon Stock | 6,000 | $125.23 | $751,380.00 |
DisclosureSEC source: 0001127602-14-024049 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,307 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.23 to $125.26, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 25, 2014 Filed Jul 29, 2014 20:30 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionCommon Stock | 6,000 | $54.97 | $329,820.00 |
DisclosureSEC source: 0001127602-14-024049 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.